Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Gary S. Firestein, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Ryan Quigley
Preventing Bone Loss in Older Adults: Do Weighted Vests or Resistance Training Work?
Ashley Baker, MSN, PMHNP
Kristen Beavers, PhD, MPH, RD
Connecting the Dots: Recognizing Systemic Clues in Sjögren’s Disease
Nancy Carteron, MD
Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
Early Rituximab Use in Sjögren’s Syndrome: A Meta-Analysis Review
GeneHarmony: Mapping Shared Genes in Autoimmune Disease
Sjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Michelle Hessen, OD
Epithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
Unmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Osteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
Charles Ginsberg, MD
Empowering Safer Movement: Fall Prevention Strategies for Osteoporosis Care
Karen Kemmis, PT, DPT, MS, FAADE
Rethinking Opioids: Key Considerations for Balancing Pain Management and Patient Risk
Martin Cheatle, PhD
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.